Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles

Abstract mRNA vaccines can be translated into protein antigens, in vivo, to effectively induce humoral and cellular immunity against these proteins. While current mRNA vaccines have generated potent immune responses, the need for ultracold storage conditions (− 80 °C) and healthcare p...

Full description

Bibliographic Details
Main Authors: Kim, Hyunjoon, Kirtane, Ameya R., Kim, Na Y., Rajesh, Netra U., Tang, Chaoyang, Ishida, Keiko, Hayward, Alison M., Langer, Robert, Traverso, Giovanni
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: Springer International Publishing 2023
Online Access:https://hdl.handle.net/1721.1/152274
_version_ 1826199371832623104
author Kim, Hyunjoon
Kirtane, Ameya R.
Kim, Na Y.
Rajesh, Netra U.
Tang, Chaoyang
Ishida, Keiko
Hayward, Alison M.
Langer, Robert
Traverso, Giovanni
author2 Koch Institute for Integrative Cancer Research at MIT
author_facet Koch Institute for Integrative Cancer Research at MIT
Kim, Hyunjoon
Kirtane, Ameya R.
Kim, Na Y.
Rajesh, Netra U.
Tang, Chaoyang
Ishida, Keiko
Hayward, Alison M.
Langer, Robert
Traverso, Giovanni
author_sort Kim, Hyunjoon
collection MIT
description Abstract mRNA vaccines can be translated into protein antigens, in vivo, to effectively induce humoral and cellular immunity against these proteins. While current mRNA vaccines have generated potent immune responses, the need for ultracold storage conditions (− 80 °C) and healthcare professionals to administer the vaccine through the parenteral route has somewhat limited their distribution in rural areas and developing countries. Overcoming these challenges stands to transform future deployment of mRNA vaccines. In this study, we developed an mRNA vaccine that can trigger a systemic immune response through administration via the gastrointestinal (GI) tract and is stable at 4 °C. A library of cationic branched poly(β-amino ester) (PBAE) polymers was synthesized and characterized, from which a polymer with high intracellular mRNA delivery efficiency and immune stimulation capacity was down-selected. mRNA vaccines made with the lead polymer-elicited cellular and humoral immunity in mice. Furthermore, lyophilization conditions of the formulation were optimized to enable storage under refrigeration. Our results suggest that PBAE nanoparticles are potent mRNA delivery platforms that can elicit B cell and T cell activation, including antigen-specific cellular and humoral responses. This system can serve as an easily administrable, potent oral mRNA vaccine. Graphical Abstract
first_indexed 2024-09-23T11:19:10Z
format Article
id mit-1721.1/152274
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:19:10Z
publishDate 2023
publisher Springer International Publishing
record_format dspace
spelling mit-1721.1/1522742024-01-19T20:47:14Z Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles Kim, Hyunjoon Kirtane, Ameya R. Kim, Na Y. Rajesh, Netra U. Tang, Chaoyang Ishida, Keiko Hayward, Alison M. Langer, Robert Traverso, Giovanni Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology. Division of Comparative Medicine Massachusetts Institute of Technology. Department of Chemical Engineering Massachusetts Institute of Technology. Department of Mechanical Engineering Abstract mRNA vaccines can be translated into protein antigens, in vivo, to effectively induce humoral and cellular immunity against these proteins. While current mRNA vaccines have generated potent immune responses, the need for ultracold storage conditions (− 80 °C) and healthcare professionals to administer the vaccine through the parenteral route has somewhat limited their distribution in rural areas and developing countries. Overcoming these challenges stands to transform future deployment of mRNA vaccines. In this study, we developed an mRNA vaccine that can trigger a systemic immune response through administration via the gastrointestinal (GI) tract and is stable at 4 °C. A library of cationic branched poly(β-amino ester) (PBAE) polymers was synthesized and characterized, from which a polymer with high intracellular mRNA delivery efficiency and immune stimulation capacity was down-selected. mRNA vaccines made with the lead polymer-elicited cellular and humoral immunity in mice. Furthermore, lyophilization conditions of the formulation were optimized to enable storage under refrigeration. Our results suggest that PBAE nanoparticles are potent mRNA delivery platforms that can elicit B cell and T cell activation, including antigen-specific cellular and humoral responses. This system can serve as an easily administrable, potent oral mRNA vaccine. Graphical Abstract 2023-09-27T18:31:08Z 2023-09-27T18:31:08Z 2023-08-17 2023-08-20T03:10:14Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/152274 The AAPS Journal. 2023 Aug 17;25(5):81 PUBLISHER_CC en https://doi.org/10.1208/s12248-023-00844-z Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ The Author(s) application/pdf Springer International Publishing Springer International Publishing
spellingShingle Kim, Hyunjoon
Kirtane, Ameya R.
Kim, Na Y.
Rajesh, Netra U.
Tang, Chaoyang
Ishida, Keiko
Hayward, Alison M.
Langer, Robert
Traverso, Giovanni
Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title_full Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title_fullStr Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title_full_unstemmed Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title_short Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
title_sort gastrointestinal delivery of an mrna vaccine using immunostimulatory polymeric nanoparticles
url https://hdl.handle.net/1721.1/152274
work_keys_str_mv AT kimhyunjoon gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT kirtaneameyar gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT kimnay gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT rajeshnetrau gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT tangchaoyang gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT ishidakeiko gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT haywardalisonm gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT langerrobert gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles
AT traversogiovanni gastrointestinaldeliveryofanmrnavaccineusingimmunostimulatorypolymericnanoparticles